Neutrophil gelatinase-associated lipocalin and interleukin-6: Potential biomarker for asthma- COPD overlap, differentiation from asthma and COPD

References

• Burrowes KS, Doel T, Brightling C. Computational modeling of the obstructive lung diseases asthma and COPD. J Transl Med. 2014;12(Suppl 2):S5.
   PubMedGoogle Scholar
• de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, Middle-aged and elderly people from the general population. PLoS One. 2013;8(5):e62985.
   PubMed Web of Science ®Google Scholar
• Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD. 2011;8(6):400–407.
   PubMedGoogle Scholar
• Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the national health and nutrition examination survey, 1988-1994. Arch Intern Med. 2000;160(11):1683–1689.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365.
   PubMed Web of Science ®Google Scholar
• Mendy A, Forno E, Niyonsenga T, et al. Prevalence and features of asthma-COPD overlap in the United States 2007-2012. Clin Respir J. 2018;12(8):2369–2377.
   PubMed Web of Science ®Google Scholar
• Hosseini M, Almasi-Hashiani A, Sepidarkish M, et al. Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and Meta-analysis. Respir Res. 2019;20(1):229.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107(7):1053–1060.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. 2018. GOLD works with healthcare professionals and public health officials around the world to raise awareness of COPD and to improve prevention and treatment of this lung disease. https://goldcopd.org/.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of COPD. 2016. https://ginasthma.org/
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of COPD. 2020. GOLD works with healthcare professionals and public health officials around the world to raise awareness of COPD and to improve prevention and treatment of this lung disease. https://goldcopd.org/.
   Google Scholar
• Singer E, Marko L, Paragas N, et al. Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications. Acta Physiol (Oxf). 2013;207(4):663–672.
   PubMed Web of Science ®Google Scholar
• Asimakopoulou A, Weiskirchen S, Weiskirchen R. Lipocalin 2 (LCN2) expression in hepatic malfunction and therapy. Front Physiol. 2016;7:430.
   PubMed Web of Science ®Google Scholar
• Bouchet S, Bauvois B. Neutrophil gelatinase-associated lipocalin (NGAL), Pro-Matrix metalloproteinase-9 (pro-MMP-9) and their complex Pro-MMP-9/NGAL in leukaemias. Cancers (Basel). 2014;6(2):796–812.
   PubMed Web of Science ®Google Scholar
• Tho NV, Park HY, Nakano Y. Asthma-COPD overlap syndrome (ACOS): a diagnostic challenge. Respirology. 2016;21(3):410–418.
   PubMed Web of Science ®Google Scholar
• Matsuda T, Kishimoto T. Interleukin 6. Encyclopedia of immunology. Second Edition ed1998. 1458–61.
   Google Scholar
• Hirano T. Interleukin 6 and its receptor: ten years later. Int Rev Immunol. 1998;16(3–4):249–284.
   PubMedGoogle Scholar
• Mehrotra N, Freire AX, Bauer DC, et al. Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score. Ann Epidemiol. 2010;20(3):223–232.
   PubMed Web of Science ®Google Scholar
• Sin DD, Miravitlles M, Mannino DM, Soriano JB, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48(3):664–673.
   PubMed Web of Science ®Google Scholar
• Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis. 2008;52(3):595–605.
   PubMed Web of Science ®Google Scholar
• Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med. 1997;155(2):449–453.
   PubMed Web of Science ®Google Scholar
• Ekberg-Jansson A, Andersson B, Bake B, et al. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT. Respir Med. 2001;95(5):363–373.
   PubMed Web of Science ®Google Scholar
• Eagan TM, Damas JK, Ueland T, et al. Neutrophil gelatinase-associated lipocalin: a biomarker in COPD. Chest. 2010;138(4):888–895.
   PubMed Web of Science ®Google Scholar
• Cowland JB, Sorensen OE, Sehested M, et al. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol. 2003;171(12):6630–6639.
   PubMed Web of Science ®Google Scholar
• Soni SS, Cruz D, Bobek I, et al. NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol. 2010;42(1):141–150.
   PubMed Web of Science ®Google Scholar
• Iwamoto H, Gao J, Koskela J, et al. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap. Eur Respir J. 2014;43(2):421–429.
   PubMed Web of Science ®Google Scholar
• Hristova Z, Tsachev K. Novel structural biomarkers for assessment of renal function and early diagnosis of acute kidney injury. Med Rev. 2013;49(4):5–13.
   Google Scholar
• Betsuyaku T, Nishimura M, Takeyabu K, et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med. 1999;159(6):1985–1991.
   PubMed Web of Science ®Google Scholar
• Yan L, Borregaard N, Kjeldsen L, et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem. 2001;276(40):37258–37265.
   PubMed Web of Science ®Google Scholar
• Roudkenar MH, Kuwahara Y, Baba T, et al. Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions. J Radiat Res. 2007;48(1):39–44.
   PubMed Web of Science ®Google Scholar
• Fu JJ, McDonald VM, Gibson PG, et al. Systemic inflammation in older adults with Asthma-COPD overlap syndrome. Allergy Asthma Immunol Res. 2014;6(4):316–324.
   PubMed Web of Science ®Google Scholar
• Gao J, Iwamoto H, Koskela J, et al. Characterization of sputum biomarkers for asthma-COPD overlap syndrome. COPD. 2016;11:2457–2465.
   Google Scholar
• Wang J, Lv H, Luo Z, et al. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD. Respir Res. 2018;19(1):47.
   PubMedGoogle Scholar
• Gelb AF, Christenson SA, Nadel JA. Understanding the pathophysiology of the asthma-chronic obstructive pulmonary disease overlap syndrome. Curr Opin Pulm Med. 2016;22(2):100–105.
   PubMed Web of Science ®Google Scholar
• Jo YS, Lee J, Yoon HI, et al. Different prevalence and clinical characteristics of asthma-chronic obstructive pulmonary disease overlap syndrome according to accepted criteria. Ann Allergy Asthma Immunol. 2017;118(6):696–703 e1.
   PubMed Web of Science ®Google Scholar
• Menezes AMB, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297–304.
   PubMed Web of Science ®Google Scholar
• Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014;44(2):341–350.
   PubMed Web of Science ®Google Scholar
• Rhee CK, Yoon HK, Yoo KH, Kim YS, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD. 2014;11(2):163–170.
   PubMedGoogle Scholar
• Tu X, Donovan C, Kim RY, et al. Asthma-COPD overlap: current understanding and the utility of experimental models. Eur Respir Rev. 2021;30(159):190185.
   PubMed Web of Science ®Google Scholar
• Vedel-Krogh S, Nielsen SF, Lange P, et al. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The copenhagen general population study. Am J Respir Crit Care Med. 2016;193(9):965–974.
   PubMed Web of Science ®Google Scholar